| 查看: 5660 | 回复: 10 | |||
[交流]
cancer research 投稿要求
|
|||
| 想请教一下，cancer research的投稿有什么要求吗？文章格式有什么要求吗？ |
回复此楼» 猜你喜欢
面上再次挂了，太难了，躺也躺不了，倦也卷不过，小学校之殇！
已经有27人回复
-
8月时间戳变的，举个手。玩一下，释放压力
已经有4人回复
-
UV压敏胶开发
已经有6人回复
-
有没有H口的？有收到消息的吗？
已经有3人回复
-
十年后又回来了，论文投稿求助
已经有3人回复
-
纯娱乐，不喜欢勿喷
已经有10人回复
-
面上提前没消息，有中的吗
已经有18人回复
-
娱乐
已经有4人回复
-
系统今天又提示维护了，估计离放榜不远了
已经有16人回复
-
一个有机合成实验室都需要哪些设备？
已经有10人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- sci期刊最新变化！
已经有30人回复
- 投过Journal of Nanoparticle Research帮忙：此期刊对形成机理的解释有要求吗
已经有3人回复
- British Journal of Cancer投稿
已经有9人回复
- African Journal of Microbiology Research老是要求我审稿，怎么办
已经有4人回复
- 求助生物、医学类1分左右的SCI投稿期刊选择（论文内容为癌症细胞的生物学研究）
已经有5人回复
- Research Highlights的格式需要怎么写才符合杂志要求
已经有9人回复
- 投稿Nano Research & J. Mater. Chem. ?
已经有19人回复
- 想投European Journal of Medicinal Chemistry，投稿要求怎么找啊？
已经有3人回复
- 【转载】A Postdoctoral Position in Hematological Cancer Research
已经有1人回复
- 关于 SCI 中 常见缩写的规则
已经有18人回复
» 抢金币啦！回帖就可以得到:
-
助理研究员——吉林大学-苏州国家实验室光电半导体智能设计与应用团队
+1/474
-
2027年博士生（硕博连读/直博）吉林大学-苏州国家实验室光电半导体智能设计与应用团队
+1/472
-
1-甲基-1,2-双(三甲基硅氧基)乙烷（CAS：17887-27-3）
+1/99
-
1,2-双(三甲基硅氧基)苯（CAS：5075-52-5）
+1/99
-
乙二醇二甲基环硅醚（CAS：57915-66-9）
+1/99
-
1,2-双(三甲基硅氧基)乙烷（CAS：7381-30-8 ）
+1/98
-
1,3,2-Dioxaphospholane, 2-(2,2,2-trifluoroethoxy)-
+1/97
-
三(三甲基硅基)甘油醚（CAS：6787-10-6 ）
+1/97
-
威格科技张德龙：二十年深耕，铸就国产惰性气氛设备新高度
+1/82
-
具身智能机器人公司招聘机械结构岗位（工程师、专家、负责人均可）薪酬最高150万
+1/82
-
国家纳米科学中心段鹏飞课题组招收2027年入学博士研究生
+1/77
-
药化高级研究员
+1/77
-
连续氢化反应中流量控制器、背压控制器的应用 | Alicat 气液压力测控全局解决方案
+2/48
-
有机合成高级研究员
+1/27
-
双一流高校招收博士（现代技术管理/环境技术经济管理）及硕士研究生（长期有效）
+1/23
-
北理工集成电路杰青团队 | 诚招科助理
+1/18
-
北理工集成电路杰青团队 | 诚招科助理
+1/17
-
苏州大学李刚教授课题组博士后招聘公告
+1/13
-
福建师范大学海峡柔性电子学院-2027年9月入学博士-考核制-电催、能源
+1/12
-
国家自然科学基金申报者发榜前心理状态调查，麻烦帮忙填一下哇！
+1/3
★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
看天: 金币+2, 鼓励一下 2012-11-20 21:10:49
小木虫: 金币+0.5, 给个红包，谢谢回帖
看天: 金币+2, 鼓励一下 2012-11-20 21:10:49
2楼2012-11-16 17:39:30
3楼2012-11-16 20:37:01
4楼2012-11-19 04:22:18
5楼2012-11-20 13:40:02
6楼2012-11-20 18:49:42
7楼2012-11-21 10:46:04
8楼2014-02-03 23:51:23
9楼2014-02-03 23:52:08
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
Cancer Research (CanRes): Instructions for Authors SmartSubmit Scope Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention, and epidemiologic research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology. Please note that the journal is unable to entertain pre-submission inquiries. See the Submission Procedures section of the Instructions for Authors for information on submitting a manuscript for consideration. Papers are stringently reviewed, and only those that report results of novel, timely, and broadly-significant research meeting high standards of scientific merit are accepted for publication. The following criteria provide an overview of the types of studies considered by the journal: Findings which have not been previously published in another tumor model. Studies performed in multiple cell lines. Conclusions which are not representative of incremental findings. Studies which include a clearly written title and abstract which communicate the study's impact of significance to non-experts. An incisive rationale that could interest a broad audience. Manuscripts containing in vivo data. Although in vivo data is not required, studies containing this data are preferred. A potentially generalizable, broad impact conclusion. Studies which describe RNA interference (RNAi) must contain one non-specific control and two specific siRNAs for each knockdown target of interest. Additional data showing that knockdown at the level of protein expression (not just mRNA) was achieved is required. Categories of Publication Top The following types of articles will be considered for publication. Note that word counts are exclusive of references. Authors are advised that submissions not adhering to the guidelines provided below, including word counts, may be returned unreviewed. Research Articles Original studies offering broad impact across the fields of basic, preclinical, clinical, prevention and epidemiologic cancer research. The reports should be well-documented, novel, and significant to the field as a whole. The Editor-in-Chief and members of the senior editorial board reserve the right to edit title, abstract, and précis for articles that are accepted to improve their clarity, brevity, and quality. 250-word abstract 5,000 words of text 7 tables and/or figures (Please keep the number of panels per figure to an absolute minimum) 50 references Priority Reports Short, definitive reports of findings of high impact, significance, and timeliness. These reports receive an accelerated review. Papers submitted as Priority Reports should include a section for Materials and Methods as well as Results and Discussion (Results and Discussion may be combined but Materials and Methods may not be combined with any other section). The Editor-in-Chief and members of the senior editorial board reserve the right to edit title, abstract, and précis for articles that are accepted, to improve their clarity, brevity, and quality. 250-word abstract 2,500 words of text 4 tables and/or figures — Please note that each figure or table is limited to a maximum of 4 panels. 20 references Reviews Articles that review a timely subject important to cancer researchers. Reviews must be written as concisely as possible. Authors of unsolicited Review Articles must first submit an outline of the proposed article for consideration. The outline should be sent to the attention of Dr. Danny R. Welch, Deputy Editor for Reviews (Fax: (215) 440-9354; E-mail: cancerres@aacr.org). All Review Articles, whether invited or not, will be subject to peer review. The length restrictions for this category of publication are provided below. Longer reviews will be considered only at the discretion of the Deputy Editor for Reviews. 200-word abstract 2,000 words of text 1 original figure with a maximum of 4 panels 30 references Perspectives in Cancer Research Articles that present fresh insights on a very active or underdeveloped area of research, with a personal viewpoint on the area, its pressing issues, or its development. 200-word abstract 3,000 words of text 3 tables and/or figures, each with a maximum of 4 panels 30 references Public Issues Brief articles on topics of interest to cancer researchers and the general public. These topics might include articles on advocacy for funding cancer research, government relations, training in the field, public education, or science education. 2,000 words of text Letters to the Editor In the spirit of open scientific dialogue, the Editors invite the submission of correspondence that presents considered opinions in response to articles published in the journal. Letters to the Editor will be peer reviewed and, if found to meet the requisite publication criteria (scholarly commentary on a subject of importance and interest to the broad readership), the Letter may be sent to the author(s) of the originally published article and possibly to other interested parties for a response to be published in the same issue of the journal as the Letter. Please note that the journal will not consider Letters to the Editor regarding Cancer Research articles that were published more than 3 months prior. Correspondence concerning articles that have not been published in Cancer Research will not be considered. The length restrictions for this category of publication are as follows: 400 words of text 5 references, the first of which must be the citation for the original article under discussion Letters may contain figures or tables only if they show data that refute the conclusions of the originating article. Figures or tables showing unpublished data in support of the conclusions of the originating article will not be considered. Include a title: "Running title of the original article" — Letter Meeting Reports Brief reports of symposia and conferences in cancer research. Reports must be submitted within 2 months of the meeting date in order to maintain their timeliness. Only those Meeting Reports dealing with topics of interest to the readership that contain novel information and insights from the meeting will be accepted for publication. A Meeting Report should offer a thoughtful, critical commentary that shows an appreciation of the connections among various presentations and reveals the consensus, if any, that emerged on matters of importance at the meeting. Before submitting a Meeting Report for consideration, potential authors must send a letter to the attention of Dr. Mariano Barbacid, Deputy Editor for Meeting Reports, to inquire whether the suggested meeting satisfies criteria for consideration. Letters of inquiry should be sent to the Publications Office (Fax: (215) 440-9354; E-mail: cancerres@aacr.org). Length restrictions for this category of publication are as follows: 100 word abstract 2,500 words of text Figures and/or tables are not permitted without prior approval from the Editors References, if necessary, must be kept to a minimum A statement of the purpose of the meeting, an integrated summary of the findings presented, and recommendations for future research The names and affiliations of key speakers should be given in an appendix that is submitted as supplemental information, not as part of the manuscript text Mathematical Oncology Research Articles Published in the Integrated Systems and Technologies section of the journal, Mathematical Oncology articles include mathematical approaches to problems in cancer research. These articles will contain new testable hypotheses, integration of theory and experimental data, facilitation of wide-ranging investigations, and basic laws of biology. The format and length restrictions for this category of publication are as follows: Title: 150 characters (not including spaces) Abstract: 350 words, in the following construction: Summarize the background, cancer significance, and question "set the stage"  Describe the findings ("deliver the result" Summarize the meaning and implication of the advance ("place in context" Succinct nonmathematical description of the major results; please use the subheading Major Findings to differentiate this portion of the abstract Quick Guide to Equations and Assumptions: Up to 5 equations, 800 words maximum Present key equations; for each, include a description and/or definition of the components of the equation Present all major assumptions of the model Body Text: 5,000 text words Figures and/or Tables: maximum of 7. Authors are asked to keep the number of panels per figure to an absolute minimum. Acceptable formats: TIFF, EPS, PPT Submit figures and tables as separate files References: 50 Supplementary Material: Submit the details of the computational procedures and a flowchart of the algorithm(s) as Supplementary Material. Cancer Research encourages that all programs used in the calculations or detailed instructions to replicate the major findings also be provided as Supplementary Material. Prior to depositing a program, you must ensure and attest that the posted version executes properly. Deposit data used for analysis (curve fitting, approximations, parameter estimation, etc.) as Supplementary Material. |
10楼2014-02-04 03:03:16
11楼2014-08-12 17:11:11